You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Cinnarizine Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Cinnarizine is an antihistamine and calcium channel blocker of the diphenylmethylpiperazine group. It is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease.
The global Cinnarizine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Cinnarizine production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Cinnarizine by regions (countries) and by Application.
The global Cinnarizine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Cinnarizine market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Cinnarizine markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Cinnarizine market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
The report includes comprehensive company profiling of leading and emerging companies competing in the global Cinnarizine market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Cinnarizine market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Cinnarizine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Cinnarizine market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Cinnarizine market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Cinnarizine market by each application segment for the same period.
This report includes the following manufacturers:
Goodwill Pharma
Gedeon Richter
Johnson and Johnson
Aurobindo Pharma
Nidda Healthcare
Leti Pharma
Allena Pharmaceuticals
Inga Laboratories
March Pharma
Market Segment by Type
Drug Store
Market Segment by Application
Antiemetic Agent
Histamine H₁-Receptor Antagonist
Antivertigo Agent
Research Methodology
To compile the detailed study of the global Cinnarizine market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Cinnarizine market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Cinnarizine market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Cinnarizine Market Size Growth Rate by Type
1.2.2 Hospital
1.2.3 Drug Store
1.2.4 On-line
1.3 Market Segment by Application
1.3.1 Global Cinnarizine Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Antiemetic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.3.4 Antivertigo Agent
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Cinnarizine Market Size (2016-2027)
2.1.1 Global Cinnarizine Revenue (2016-2027)
2.1.2 Global Cinnarizine Sales (2016-2027)
2.2 Global Cinnarizine Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Cinnarizine Sales by Regions (2016-2021)
2.2.2 Global Cinnarizine Revenue by Regions (2016-2021)
2.3 Global Cinnarizine Market Size Forecast by Region
2.3.1 Global Cinnarizine Sales Forecast by Region (2022-2027)
2.3.2 Global Cinnarizine Revenue Forecast by Region (2022-2027)
2.4 Global Top Cinnarizine Regions (Countries) Ranking by Market Size
2.5 Cinnarizine Industry Trends
2.5.1 Cinnarizine Market Trends
2.5.2 Cinnarizine Market Drivers
2.5.3 Cinnarizine Market Challenges
2.5.4 Cinnarizine Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Cinnarizine Manufacturers by Sales (2016-2021)
3.1.1 Global Cinnarizine Sales by Manufacturers (2016-2021)
3.1.2 Global Cinnarizine Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Cinnarizine Sales in 2020
3.2 Global Top Manufacturers Cinnarizine by Revenue
3.2.1 Global Cinnarizine Revenue by Manufacturers (2016-2021)
3.2.2 Top Cinnarizine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Cinnarizine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cinnarizine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cinnarizine as of 2020)
3.4 Global Cinnarizine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Cinnarizine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Cinnarizine Market
3.7 Key Manufacturers Cinnarizine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Cinnarizine Market Size by Type
4.1 Global Cinnarizine Historic Market Review by Type (2016-2021)
4.1.1 Global Cinnarizine Sales Market Share by Type (2016-2021)
4.1.2 Global Cinnarizine Revenue Market Share by Type (2016-2021)
4.1.3 Cinnarizine Price by Type (2016-2021)
4.2 Global Cinnarizine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Cinnarizine Sales Forecast by Type (2022-2027)
4.2.2 Global Cinnarizine Revenue Forecast by Type (2022-2027)
4.2.3 Cinnarizine Price Forecast by Type (2022-2027)

5 Global Cinnarizine Market Size by Application
5.1 Global Cinnarizine Historic Market Review by Application (2016-2021)
5.1.1 Global Cinnarizine Sales Market Share by Application (2016-2021)
5.1.2 Global Cinnarizine Revenue Market Share by Application (2016-2021)
5.1.3 Cinnarizine Price by Application (2016-2021)
5.2 Global Cinnarizine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Cinnarizine Sales Forecast by Application (2022-2027)
5.2.2 Global Cinnarizine Revenue Forecast by Application (2022-2027)
5.2.3 Cinnarizine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Cinnarizine Sales Breakdown by Company
6.1.1 North America Cinnarizine Sales by Company (2016-2027)
6.1.2 North America Cinnarizine Revenue by Company (2016-2027)
6.2 North America Cinnarizine Market Size by Type (2016-2027)
6.2.1 North America Cinnarizine Sales by Type (2016-2027)
6.2.2 North America Cinnarizine Revenue by Type (2016-2027)
6.3 North America Cinnarizine Market Size by Application (2016-2027)
6.3.1 North America Cinnarizine Sales by Application (2016-2027)
6.3.2 North America Cinnarizine Revenue by Application (2016-2027)
6.4 North America Cinnarizine Market Size by Country
6.4.1 North America Cinnarizine Sales by Country (2016-2027)
6.4.2 North America Cinnarizine Revenue by Country (2016-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cinnarizine Sales Breakdown by Company
7.1.1 Europe Cinnarizine Sales by Company (2016-2027)
7.1.2 Europe Cinnarizine Revenue by Company (2016-2027)
7.2 Europe Cinnarizine Market Size by Type (2016-2027)
7.2.1 Europe Cinnarizine Sales by Type (2016-2027)
7.2.2 Europe Cinnarizine Revenue by Type (2016-2027)
7.3 Europe Cinnarizine Market Size by Application (2016-2027)
7.3.1 Europe Cinnarizine Sales by Application (2016-2027)
7.3.2 Europe Cinnarizine Revenue by Application (2016-2027)
7.4 Europe Cinnarizine Market Size by Country
7.4.1 Europe Cinnarizine Sales by Country (2016-2027)
7.4.2 Europe Cinnarizine Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Cinnarizine Sales Breakdown by Company
8.1.1 Asia Pacific Cinnarizine Sales by Company (2016-2027)
8.1.2 Asia Pacific Cinnarizine Revenue by Company (2016-2027)
8.2 Asia Pacific Cinnarizine Market Size by Type (2016-2027)
8.2.1 Asia Pacific Cinnarizine Sales by Type (2016-2027)
8.2.2 Asia Pacific Cinnarizine Revenue by Type (2016-2027)
8.3 Asia Pacific Cinnarizine Market Size by Application (2016-2027)
8.3.1 Asia Pacific Cinnarizine Sales by Application (2016-2027)
8.3.2 Asia Pacific Cinnarizine Revenue by Application (2016-2027)
8.4 Asia Pacific Cinnarizine Market Size by Regions
8.4.1 Asia Pacific Cinnarizine Sales by Regions
8.4.2 Asia Pacific Cinnarizine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia

9 Latin America
9.1 Latin America Cinnarizine Sales Breakdown by Company
9.1.1 Latin America Cinnarizine Sales by Company (2016-2027)
9.1.2 Latin America Cinnarizine Revenue by Company (2016-2027)
9.2 Latin America Cinnarizine Market Size by Type (2016-2027)
9.2.1 Latin America Cinnarizine Sales by Type (2016-2027)
9.2.2 Latin America Cinnarizine Revenue by Type (2016-2027)
9.3 Latin America Cinnarizine Market Size by Application (2016-2027)
9.3.1 Latin America Cinnarizine Sales by Application (2016-2027)
9.3.2 Latin America Cinnarizine Revenue by Application (2016-2027)
9.4 Latin America Cinnarizine Market Size by Country
9.4.1 Latin America Cinnarizine Sales by Country (2016-2027)
9.4.2 Latin America Cinnarizine Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Cinnarizine Sales Breakdown by Company
10.1.1 Middle East and Africa Cinnarizine Sales by Company (2016-2027)
10.1.2 Middle East and Africa Cinnarizine Revenue by Company (2016-2027)
10.2 Middle East and Africa Cinnarizine Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Cinnarizine Sales by Type (2016-2027)
10.2.2 Middle East and Africa Cinnarizine Revenue by Type (2016-2027)
10.3 Middle East and Africa Cinnarizine Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Cinnarizine Sales by Application (2016-2027)
10.3.2 Middle East and Africa Cinnarizine Revenue by Application (2016-2027)
10.4 Middle East and Africa Cinnarizine Market Size by Country
10.4.1 Middle East and Africa Cinnarizine Sales by Country (2016-2027)
10.4.2 Middle East and Africa Cinnarizine Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Company Profiles
11.1 Goodwill Pharma
11.1.1 Goodwill Pharma Corporation Information
11.1.2 Goodwill Pharma Overview
11.1.3 Goodwill Pharma Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Goodwill Pharma Cinnarizine Products and Services
11.1.5 Goodwill Pharma Cinnarizine SWOT Analysis
11.1.6 Goodwill Pharma Recent Developments
11.2 Zambon
11.2.1 Zambon Corporation Information
11.2.2 Zambon Overview
11.2.3 Zambon Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Zambon Cinnarizine Products and Services
11.2.5 Zambon Cinnarizine SWOT Analysis
11.2.6 Zambon Recent Developments
11.3 Gedeon Richter
11.3.1 Gedeon Richter Corporation Information
11.3.2 Gedeon Richter Overview
11.3.3 Gedeon Richter Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Gedeon Richter Cinnarizine Products and Services
11.3.5 Gedeon Richter Cinnarizine SWOT Analysis
11.3.6 Gedeon Richter Recent Developments
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Corporation Information
11.4.2 Johnson and Johnson Overview
11.4.3 Johnson and Johnson Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Johnson and Johnson Cinnarizine Products and Services
11.4.5 Johnson and Johnson Cinnarizine SWOT Analysis
11.4.6 Johnson and Johnson Recent Developments
11.5 Hasco-Lek
11.5.1 Hasco-Lek Corporation Information
11.5.2 Hasco-Lek Overview
11.5.3 Hasco-Lek Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 Hasco-Lek Cinnarizine Products and Services
11.5.5 Hasco-Lek Cinnarizine SWOT Analysis
11.5.6 Hasco-Lek Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Teva Cinnarizine Products and Services
11.6.5 Teva Cinnarizine SWOT Analysis
11.6.6 Teva Recent Developments
11.7 Sopharma
11.7.1 Sopharma Corporation Information
11.7.2 Sopharma Overview
11.7.3 Sopharma Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Sopharma Cinnarizine Products and Services
11.7.5 Sopharma Cinnarizine SWOT Analysis
11.7.6 Sopharma Recent Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Overview
11.8.3 Aurobindo Pharma Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Aurobindo Pharma Cinnarizine Products and Services
11.8.5 Aurobindo Pharma Cinnarizine SWOT Analysis
11.8.6 Aurobindo Pharma Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Novartis Cinnarizine Products and Services
11.9.5 Novartis Cinnarizine SWOT Analysis
11.9.6 Novartis Recent Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Overview
11.10.3 Mylan Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 Mylan Cinnarizine Products and Services
11.10.5 Mylan Cinnarizine SWOT Analysis
11.10.6 Mylan Recent Developments
11.11 Eurogenerics
11.11.1 Eurogenerics Corporation Information
11.11.2 Eurogenerics Overview
11.11.3 Eurogenerics Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Eurogenerics Cinnarizine Products and Services
11.11.5 Eurogenerics Recent Developments
11.12 Nidda Healthcare
11.12.1 Nidda Healthcare Corporation Information
11.12.2 Nidda Healthcare Overview
11.12.3 Nidda Healthcare Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Nidda Healthcare Cinnarizine Products and Services
11.12.5 Nidda Healthcare Recent Developments
11.13 Apotex
11.13.1 Apotex Corporation Information
11.13.2 Apotex Overview
11.13.3 Apotex Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Apotex Cinnarizine Products and Services
11.13.5 Apotex Recent Developments
11.14 Leti Pharma
11.14.1 Leti Pharma Corporation Information
11.14.2 Leti Pharma Overview
11.14.3 Leti Pharma Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Leti Pharma Cinnarizine Products and Services
11.14.5 Leti Pharma Recent Developments
11.15 Allena Pharmaceuticals
11.15.1 Allena Pharmaceuticals Corporation Information
11.15.2 Allena Pharmaceuticals Overview
11.15.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Allena Pharmaceuticals Cinnarizine Products and Services
11.15.5 Allena Pharmaceuticals Recent Developments
11.16 Inga Laboratories
11.16.1 Inga Laboratories Corporation Information
11.16.2 Inga Laboratories Overview
11.16.3 Inga Laboratories Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Inga Laboratories Cinnarizine Products and Services
11.16.5 Inga Laboratories Recent Developments
11.17 March Pharma
11.17.1 March Pharma Corporation Information
11.17.2 March Pharma Overview
11.17.3 March Pharma Cinnarizine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 March Pharma Cinnarizine Products and Services
11.17.5 March Pharma Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Cinnarizine Value Chain Analysis
12.2 Cinnarizine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cinnarizine Production Mode & Process
12.4 Cinnarizine Sales and Marketing
12.4.1 Cinnarizine Sales Channels
12.4.2 Cinnarizine Distributors
12.5 Cinnarizine Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 130